Long-term effects of SARS-CoV-2 infection in hospitalized children: findings from an Italian single-center study.
COVID
Children
Hospitalized
Infection
Long COVID
Long-term effects
SARS-CoV-2
Journal
Italian journal of pediatrics
ISSN: 1824-7288
Titre abrégé: Ital J Pediatr
Pays: England
ID NLM: 101510759
Informations de publication
Date de publication:
14 Feb 2024
14 Feb 2024
Historique:
received:
09
11
2023
accepted:
15
01
2024
medline:
15
2
2024
pubmed:
15
2
2024
entrez:
14
2
2024
Statut:
epublish
Résumé
Limited evidence exists regarding the association between COVID-19 and Long COVID manifestations in children, particularly concerning variants of concern (VOCs). We aimed to characterize a cohort of pediatric patients hospitalized with confirmed acute SARS-CoV-2 and monitor them for Long COVID symptoms. Additionally, it seeks to explore any potential correlations between VOCs and clinical symptoms. We conducted a prospective study involving children hospitalized from November 2021 to March 2023, with confirmed acute SARS-CoV-2 infection. A telephone survey was conducted at 3-6-12 months after discharge. We included 167 patients (77 F/90 M). Upon hospital admission, 95.5% of patients presented as symptomatic. Regarding patients for whom it was feasible to determine the SARS-CoV-2 variant (n = 51), the Delta variant was identified in 11 children (21.6%) and Omicron variant in the remaining 40 patients (78.4%: 27.5% BA.1 variant; 15% BA.2 variant; 57.5% BA.5 variant). 19 patients (16.5%) reported experiencing at least one symptom indicative of Long COVID (weight loss 31.6%, inappetence 26.3%, chronic cough 21.1%, fatigue 21.1%, and sleep disturbances, wheezing, abdominal pain and mood disorders 15.8%). In only 4 patients with Long COVID we could identified a specific SARS-CoV-2 variant (3 Omicron: 2 BA.1 and 1 BA.2; 1 Delta). this study underscores that long COVID is a significant concern in the pediatric population. Our data reinforce the importance of continuously monitoring the impact of long-COVID in infants, children, and adolescents. A follow-up following SARS-CoV-2 infection is therefore advisable, with symptom investigation tailored to the patient's age.
Sections du résumé
BACKGROUND
BACKGROUND
Limited evidence exists regarding the association between COVID-19 and Long COVID manifestations in children, particularly concerning variants of concern (VOCs). We aimed to characterize a cohort of pediatric patients hospitalized with confirmed acute SARS-CoV-2 and monitor them for Long COVID symptoms. Additionally, it seeks to explore any potential correlations between VOCs and clinical symptoms.
METHODS
METHODS
We conducted a prospective study involving children hospitalized from November 2021 to March 2023, with confirmed acute SARS-CoV-2 infection. A telephone survey was conducted at 3-6-12 months after discharge.
RESULTS
RESULTS
We included 167 patients (77 F/90 M). Upon hospital admission, 95.5% of patients presented as symptomatic. Regarding patients for whom it was feasible to determine the SARS-CoV-2 variant (n = 51), the Delta variant was identified in 11 children (21.6%) and Omicron variant in the remaining 40 patients (78.4%: 27.5% BA.1 variant; 15% BA.2 variant; 57.5% BA.5 variant). 19 patients (16.5%) reported experiencing at least one symptom indicative of Long COVID (weight loss 31.6%, inappetence 26.3%, chronic cough 21.1%, fatigue 21.1%, and sleep disturbances, wheezing, abdominal pain and mood disorders 15.8%). In only 4 patients with Long COVID we could identified a specific SARS-CoV-2 variant (3 Omicron: 2 BA.1 and 1 BA.2; 1 Delta).
CONCLUSIONS
CONCLUSIONS
this study underscores that long COVID is a significant concern in the pediatric population. Our data reinforce the importance of continuously monitoring the impact of long-COVID in infants, children, and adolescents. A follow-up following SARS-CoV-2 infection is therefore advisable, with symptom investigation tailored to the patient's age.
Identifiants
pubmed: 38355648
doi: 10.1186/s13052-024-01596-y
pii: 10.1186/s13052-024-01596-y
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
27Subventions
Organisme : Horizon 2020
ID : COVICIS project number 101046041
Informations de copyright
© 2024. The Author(s).
Références
WHO. A Clinical Case Definition of Post COVID-19 Condition by a Delphi Consensus 2021.
Dennis A, Wamil M, Alberts J, Oben J, Cuthbertson DJ, Wootton D, Crooks M, Gabbay M, Brady M, Hishmeh L, Attree E, Heightman M, Banerjee R, Banerjee A, COVERSCAN study investigators. Multiorgan impairment in low-risk individuals with post-COVID-19 syndrome: a prospective, community-based study. BMJ Open. 2021;11(3):e048391. https://doi.org/10.1136/bmjopen-2020-048391 .
doi: 10.1136/bmjopen-2020-048391
pubmed: 33785495
Zhang P, Li J, Liu H, Han N, Ju J, Kou Y, Chen L, Jiang M, Pan F, Zheng Y, Gao Z, Jiang B. (2020). Long-term bone and lung consequences associated with hospital-acquired severe acute respiratory syndrome: a 15-year follow-up from a prospective cohort study. Bone Res. 2020;8:8. https://doi.org/10.1038/s41413-020-0084-5 . Erratum in: Bone Res. 21;8:34.
Swigris JJ, Streiner DL, Brown KK, Belkin A, Green KE, Wamboldt FS, IPFnet I. Assessing exertional dyspnea in patients with idiopathic pulmonary fibrosis. Respir Med. 2014;108(1):181–8. https://doi.org/10.1016/j.rmed.2013.12.009 .
doi: 10.1016/j.rmed.2013.12.009
pubmed: 24388667
Heiss R, Tan L, Schmidt S, Regensburger AP, Ewert F, Mammadova D, Buehler A, Vogel-Claussen J, Voskrebenzev A, Rauh M, Rompel O, Nagel AM, Lévy S, Bickelhaupt S, May MS, Uder M, Metzler M, Trollmann R, Woelfle J, Wagner AL, Knieling F. Pulmonary Dysfunction after Pediatric COVID-19. Radiology. 2023;306(3):e221250. https://doi.org/10.1148/radiol.221250 .
doi: 10.1148/radiol.221250
pubmed: 36125379
Lu Y, Li X, Geng D, Mei N, Wu PY, Huang CC, Jia T, Zhao Y, Wang D, Xiao A, Yin B. Cerebral micro-structural changes in COVID-19 patients - an MRI-based 3-month follow-up study. EClinicalMedicine. 2020;25:100484. https://doi.org/10.1016/j.eclinm.2020.100484 .
doi: 10.1016/j.eclinm.2020.100484
pubmed: 32838240
pmcid: 7396952
Matschke J, Lütgehetmann M, Hagel C, Sperhake JP, Schröder AS, Edler C, Mushumba H, Fitzek A, Allweiss L, Dandri M, Dottermusch M, Heinemann A, Pfefferle S, Schwabenland M, Sumner Magruder D, Bonn S, Prinz M, Gerloff C, Püschel K, Krasemann S, Aepfelbacher M, Glatzel M. Neuropathology of patients with COVID-19 in Germany: a post-mortem case series. Lancet Neurol. 2020;19(11):919–29. https://doi.org/10.1016/S1474-4422(20)30308-2 .
doi: 10.1016/S1474-4422(20)30308-2
pubmed: 33031735
pmcid: 7535629
Del Rio C, Collins LF, Malani P. Long-term Health consequences of COVID. JAMA. 2020;324(17):1723.
doi: 10.1001/jama.2020.19719
pubmed: 33031513
pmcid: 8019677
Raman B, Cassar MP, Tunnicliffe EM, Filippini N, Griffanti L, Alfaro-Almagro F, Okell T, Sheerin F, Xie C, Mahmod M, Mózes FE, Lewandowski AJ, Ohuma EO, Holdsworth D, Lamlum H, Woodman MJ, Krasopoulos C, Mills R, McConnell FAK, Wang C, Arthofer C, Lange FJ, Andersson J, Jenkinson M, Antoniades C, Channon KM, Shanmuganathan M, Ferreira VM, Piechnik SK, Klenerman P, Brightling C, Talbot NP, Petousi N, Rahman NM, Ho LP, Saunders K, Geddes JR, Harrison PJ, Pattinson K, Rowland MJ, Angus BJ, Gleeson F, Pavlides M, Koychev I, Miller KL, Mackay C, Jezzard P, Smith SM, Neubauer S. Medium-term effects of SARS-CoV-2 infection on multiple vital organs, exercise capacity, cognition, quality of life and mental health, post-hospital discharge. EClinicalMedicine. 2021;31:100683. https://doi.org/10.1016/j.eclinm.2020.100683 .
doi: 10.1016/j.eclinm.2020.100683
pubmed: 33490928
pmcid: 7808914
Yong SJ. (2021). Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments. Infect Dis (Lond). 202;53(10):737–754.
Karlsson AC, Humbert M, Buggert M. The known unknowns of T cell immunity to COVID. Sci Immunol. 2020;5(53):19.
doi: 10.1126/sciimmunol.abe8063
Hirotsu Y, Maejima M, Shibusawa M, Amemiya K, Nagakubo Y, Hosaka K, Sueki H, Hayakawa M, Mochizuki H, Tsutsui T, Kakizaki Y, Miyashita Y, Omata M. Analysis of a persistent viral shedding patient infected with SARS-CoV-2 by RT-qPCR, FilmArray Respiratory Panel v2.1, and antigen detection. J Infect Chemother. 2021;27(2):406–9. https://doi.org/10.1016/j.jiac.2020.10.026 .
doi: 10.1016/j.jiac.2020.10.026
pubmed: 33183963
Zuo Y, Estes SK, Ali RA, Gandhi AA, Yalavarthi S, Shi H, Sule G, Gockman K, Madison JA, Zuo M, Yadav V, Wang J, Woodard W, Lezak SP, Lugogo NL, Smith SA, Morrissey JH, Kanthi Y, Knight JS. Prothrombotic autoantibodies in serum from patients hospitalized with COVID-19. Sci Transl Med. 2020;12(570):eabd3876. https://doi.org/10.1126/scitranslmed.abd3876 .
doi: 10.1126/scitranslmed.abd3876
pubmed: 33139519
pmcid: 7724273
Gao ZW, Zhang HZ, Liu C, Dong K. Autoantibodies in COVID-19: frequency and function. Autoimmun Rev. 2021;20(3):102754. https://doi.org/10.1016/j.autrev.2021.102754 .
doi: 10.1016/j.autrev.2021.102754
pubmed: 33476817
pmcid: 7813482
Elkon K, Casali P. Nature and functions of autoantibodies. Nat Clin PractRheumatol. 2008;4(9):491–8. https://doi.org/10.1038/ncprheum0895 .
doi: 10.1038/ncprheum0895
Cojocaru M, Cojocaru IM, Silosi I, et al. Manifestations of systemic lupus erythematosus. Maedica (Bucur). 2011;6(4):330–6.
pubmed: 22879850
Guo Q, Wang Y, Xu D, Nossent J, Pavlos NJ, Xu J. Rheumatoid arthritis: pathological mechanisms and modern pharmacologic therapies. Bone Res. 2018;27:6:15. https://doi.org/10.1038/s41413-018-0016-9 .
doi: 10.1038/s41413-018-0016-9
Brodin P. Immune determinants of COVID-19 disease presentation and severity. Nat Med. 2021;27(1):28–33. https://doi.org/10.1038/s41591-020-01202-8 .
doi: 10.1038/s41591-020-01202-8
pubmed: 33442016
Yeoh YK, Zuo T, Lui GC, Zhang F, Liu Q, Li AY, Chung AC, Cheung CP, Tso EY, Fung KS, Chan V, Ling L, Joynt G, Hui DS, Chow KM, Ng SSS, Li TC, Ng RW, Yip TC, Wong GL, Chan FK, Wong CK, Chan PK, Ng SC. Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19. Gut. 2021;70(4):698–706. https://doi.org/10.1136/gutjnl-2020-323020 .
doi: 10.1136/gutjnl-2020-323020
pubmed: 33431578
Howard-Jones AR, Burgner DP, Crawford NW, Goeman E, Gray PE, Hsu P, Kuek S, McMullan BJ, Tosif S, Wurzel D, Bowen AC, Danchin M, Koirala A, Sharma K, Yeoh DK, Britton PN. COVID-19 in children. II: Pathogenesis, disease spectrum and management. J Paediatr Child Health. 2022;58(1):46–53. https://doi.org/10.1111/jpc.15811 .
doi: 10.1111/jpc.15811
pubmed: 34694037
Bova SM, Serafini L, Serati I, Fiori L, Veggiotti P. Seizures may be an early sign of acute COVID-19, and the Omicron variant could present a more epileptogenic profile. Acta Paediatr. 2022;111(9):1814–5. https://doi.org/10.1111/apa.16424 .
doi: 10.1111/apa.16424
pubmed: 35615863
Ottaviano E, Parodi C, Borghi E, Massa V, Gervasini C, Centanni S, Zuccotti G, LollipopStudy G. Saliva detection of SARS-CoV-2 for mitigating company outbreaks: a surveillance experience, Milan, Italy, March 2021. Epidemiol Infect. 2021;149:E171. https://doi.org/10.1017/S0950268821001473 .
doi: 10.1017/S0950268821001473
pubmed: 34325754
Lopez-Leon S, Wegman-Ostrosky T, Ayuzo Del Valle NC, Perelman C, Sepulveda R, Rebolledo PA, Cuapio A, Villapol S. Long-COVID in children and adolescents: a systematic review and meta-analyses. Sci Rep. 2022;12(1):9950. https://doi.org/10.1038/s41598-022-13495-5 .
doi: 10.1038/s41598-022-13495-5
pubmed: 35739136
pmcid: 9226045
Wanga V, Gerdes ME, Shi DS, Choudhary R, Dulski TM, Hsu S, Idubor OI, Webber BJ, Wendel AM, Agathis NT, Anderson K, Boyles T, Chiu SK, Click ES, Da Silva J, Dupont H, Evans M, Gold JAW, Haston J, Logan P, Maloney SA, Martinez M, Natarajan P, BMBS1, Spicer KB, Swancutt M, Stevens VA, Brown J, Chandra G, Light M, Barr FE, Snowden J, Kociolek LK, McHugh M, Wessel D, Simpson JN, Gorman KC, Breslin KA, DeBiasi RL, Thompson A, Kline MW, Boom JA, Singh IR, Dowlin M, Wietecha M, Schweitzer B, Morris SB, Koumans EH, Ko JY, Kimball AA, Siegel DA. (2021). Characteristics and Clinical Outcomes of Children and Adolescents Aged < 18 Years Hospitalized with COVID-19 - Six Hospitals, United States, July-August 2021. MMWR Morb Mortal Wkly Rep. 70(5152):1766–1772. https://doi.org/10.15585/mmwr.mm705152a3 . Erratum in: MMWR Morb Mortal Wkly Rep. 2022;71(5):185.
Delahoy MJ, Ujamaa D, Whitaker M, O’Halloran A, Anglin O, Burns E, Cummings C, Holstein R, Kambhampati AK, Milucky J, Patel K, Pham H, Taylor CA, Chai SJ, Reingold A, Alden NB, Kawasaki B, Meek J, Yousey-Hindes K, Anderson EJ, Openo KP, Teno K, Weigel A, Kim S, Leegwater L, Bye E, Como-Sabetti K, Ropp S, Rudin D, Muse A, Spina N, Bennett NM, Popham K, Billing LM, Shiltz E, Sutton M, Thomas A, Schaffner W, Talbot HK, Crossland MT, McCaffrey K, Hall AJ, Fry AM, McMorrow M, Reed C, Garg S, Havers FP, COVID-NET Surveillance Team; COVID-NET Surveillance Team. Hospitalizations Associated with COVID-19 among children and adolescents - COVID-NET, 14 States, March 1, 2020-August 14, 2021. MMWR Morb Mortal Wkly Rep. 2021;70(36):1255–60. https://doi.org/10.15585/mmwr.mm7036e2 .
doi: 10.15585/mmwr.mm7036e2
pubmed: 34499627
pmcid: 8437052
Bloise S, Isoldi S, Marcellino A, De Luca E, Dilillo A, Mallardo S, Martucci V, Sanseviero M, Del Giudice E, Iorfida D, Leone R, Testa A, Frasacco B, Gizzone P, Proietti Ciolli C, Sinceri A, Zuliani F, Zanardi E, Gambarotto A, Lisa Grandinetti A, Ventriglia F, Lubrano R. (2022). Clinical picture and long-term symptoms of SARS-CoV-2 infection in an Italian pediatric population. Ital J Pediatr. 2022 48(1):79. https://doi.org/10.1186/s13052-022-01270-1 .
Zimmermann P, Pittet LF, Curtis N. How common is long COVID in children and adolescents? Pediatr Infect Dis J. 2021;40(12):e482–7. https://doi.org/10.1097/INF.0000000000003328 .
doi: 10.1097/INF.0000000000003328
pubmed: 34870392
pmcid: 8575095
Sudre CH, Murray B, Varsavsky T, Graham MS, Penfold RS, Bowyer RC, et al. Attributes and predictors of long COVID. Nat Med. 2021;27:626–31.
doi: 10.1038/s41591-021-01292-y
pubmed: 33692530
pmcid: 7611399
Jacobson KB, Rao M, Bonilla H, Subramanian A, Hack I, Madrigal M, et al. Patients with uncomplicated COVID-19 have long-term persistent symptoms and functional impairment similar to patients with severe COVID-19: a cautionary tale during a global pandemic. Clin Infect Dis. 2021;73:e826–9.
doi: 10.1093/cid/ciab103
pubmed: 33624010
Molteni E, Sudre CH, Canas LS, Bhopal SS, Hughes RC, Antonelli M, Murray B, Kläser K, Kerfoot E, Chen L, Deng J, Hu C, Selvachandran S, Read K, Capdevila Pujol J, Hammers A, Spector TD, Ourselin S, Steves CJ, Modat M, Absoud M, Duncan EL. (2021). Illness duration and symptom profile in symptomatic UK school-aged children tested for SARS-CoV-2. Lancet Child Adolesc Health. 5(10):708–718. https://doi.org/10.1016/S2352-4642(21)00198-X . Epub 2021 Aug 3. Erratum in: Lancet Child Adolesc Health. 2021.
Meherali S, Punjani N, Louie-Poon S, Abdul Rahim K, Das JK, Salam RA, Lassi ZS. Mental Health of children and adolescents amidst COVID-19 and Past Pandemics: a Rapid systematic review (2021). Int J Environ Res Public Health 18(7):3432. https://doi.org/10.3390/ijerph18073432 .
Davis HE, McCorkell L, Vogel JM, Topol EJ, Long COVID. major findings, mechanisms and recommendations (2023). Nat Rev Microbiol. 21(3):133–146. https://doi.org/10.1038/s41579-022-00846-2 . Epub 2023 Jan 13. Erratum in: Nat Rev Microbiol. 2023;21(6):408.
Sandmann FG, Tessier E, Lacy J, Kall M, Van Leeuwen E, Charlett A et al. Long-term health-related quality of life in non-hospitalized coronavirus disease 2019 (COVID-19) cases with confirmed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in England: longitudinal analysis and cross-sectional comparison with controls (2022). Clin Infect Dis 75(1):e962–73.
Chuang HJ, Lin CW, Hsiao MY, Wang TG, Liang HW. (2023). Long COVID and rehabilitation. J Formos Med Assoc. S0929-6646(23)00107-9. https://doi.org/10.1016/j.jfma.2023.03.022 . Epub ahead of print. PMID: 37061399; PMCID: PMC10101546.
Kritikos A, Caruana G, Lazor-Blanchet C, Currat M, Chiche JD, Vollenweider P, Bart PA, Opota O, Greub G. Comparison of nasopharyngeal and saliva swab nucleic acid amplification and Rapid Antigen Testing to detect Omicron SARS-CoV-2 variant of concern: a prospective clinical trial (OMICRON). MicrobiolSpectr. 2022;10(6):e0392322. https://doi.org/10.1128/spectrum.03923-22 .
doi: 10.1128/spectrum.03923-22